Skip to main content
. 2007 Jul 6;11(4):R73. doi: 10.1186/cc5960

Table 4.

Incidence and type of serious adverse events

Variable Placebo group (n = 29) Selenium group (n = 31) P value
At least one serious adverse event 18 (62) 25 (81) 0.111
Type of event
 Respiratory failure 1 (3) 5 (16) 0.196
 Cardiac failure 1 (3) 1 (3) 1.000
 Renal failure 1 (3) 0 (0) 0.483
 Ischaemic event 6 (21) 2 (7) 0.134
 Intracranial haemorrhage 1 (3) 1 (3) 1.000
 Refractory shock 6 (21) 5 (16) 0.648
 Multiorgan failure 4 (14) 10 (32) 0.091
 Superinfection 2 (7) 1 (3) 0.606
 Othersa 0 (0) 2 (7) 0.492

Data presented as n (%). aIncludes one thrombocytopenia and one radial artery pseudoaneurysm.

HHS Vulnerability Disclosure